RDF of MGI data
pubmed
Jutta. Lamlé, et.al., Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury., Gastroenterology, 2008, 134
http://rdf.ncbi.nlm.nih.gov/pubmed/18395094
Jutta. Lamlé, et.al., Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury., Gastroenterology, 2008, 134(pubmed)
ダウンロード
SPARQL
足あと
問い合わせ
URI表示モード
Jutta. Lamlé, et.al., Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury., Gastroenterology, 2008, 134
pubmed
表現型アノテーション
http://purl.org/net/cito/citesAsAuthority
hepatic steatosis_Nfe2l2<tm1Mym>/Nfe2l2<tm1Mym>
http://metadb.riken.jp/0002628I129P2OlaHsdC57BL6Nfe2l2tm1MymNfe2l2tm1MymNfe2l2tm1Mym
increased sensitivity to xenobiotic induced morbidity/mortality_Nfe2l2<tm1Mym>/Nfe2l2<tm1Mym>
http://metadb.riken.jp/0009766I129P2OlaHsdC57BL6Nfe2l2tm1MymNfe2l2tm1MymNfe2l2tm1Mym
increased circulating alanine transaminase level_Nfe2l2<tm1Mym>/Nfe2l2<tm1Mym>
http://metadb.riken.jp/0002941I129P2OlaHsdC57BL6Nfe2l2tm1MymNfe2l2tm1MymNfe2l2tm1Mym
increased hepatocyte apoptosis_Nfe2l2<tm1Mym>/Nfe2l2<tm1Mym>
http://metadb.riken.jp/0003887I129P2OlaHsdC57BL6Nfe2l2tm1MymNfe2l2tm1MymNfe2l2tm1Mym
abnormal physiological response to xenobiotic_Nfe2l2<tm1Mym>/Nfe2l2<tm1Mym>
http://metadb.riken.jp/0008872I129P2OlaHsdC57BL6Nfe2l2tm1MymNfe2l2tm1MymNfe2l2tm1Mym
increased circulating tumor necrosis factor level_Nfe2l2<tm1Mym>/Nfe2l2<tm1Mym>
http://metadb.riken.jp/0008553I129P2OlaHsdC57BL6Nfe2l2tm1MymNfe2l2tm1MymNfe2l2tm1Mym
liver inflammation_Nfe2l2<tm1Mym>/Nfe2l2<tm1Mym>
http://metadb.riken.jp/0001860I129P2OlaHsdC57BL6Nfe2l2tm1MymNfe2l2tm1MymNfe2l2tm1Mym
increased circulating interleukin-6 level_Nfe2l2<tm1Mym>/Nfe2l2<tm1Mym>
http://metadb.riken.jp/0008596I129P2OlaHsdC57BL6Nfe2l2tm1MymNfe2l2tm1MymNfe2l2tm1Mym
cachexia_Nfe2l2<tm1Mym>/Nfe2l2<tm1Mym>
http://metadb.riken.jp/0005150I129P2OlaHsdC57BL6Nfe2l2tm1MymNfe2l2tm1MymNfe2l2tm1Mym
hypoglycemia_Nfe2l2<tm1Mym>/Nfe2l2<tm1Mym>
http://metadb.riken.jp/0000189I129P2OlaHsdC57BL6Nfe2l2tm1MymNfe2l2tm1MymNfe2l2tm1Mym
表現型アノテーション
http://purl.org/net/cito/citesAsAuthority
hypoglycemia in RBRC00984
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001708
increased hepatocyte apoptosis in RBRC01236
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017928
increased circulating tumor necrosis factor level in RBRC01236
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017946
increased circulating interleukin-6 level in RBRC00984
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001748
hypoglycemia in RBRC01390
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002601
hepatic steatosis in RBRC01390
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002616
cachexia in RBRC01390
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002631
cachexia in RBRC01236
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017937
liver inflammation in RBRC02190
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003804
increased circulating tumor necrosis factor level in RBRC02190
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003837
liver inflammation in RBRC02414
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004381
liver inflammation in RBRC01236
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017912
increased circulating alanine transaminase level in RBRC02414
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004392
increased circulating alanine transaminase level in RBRC00984
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001725
increased sensitivity to xenobiotic induced morbidity/mortality in RBRC01236
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017955
hepatic steatosis in RBRC00984
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001723
increased sensitivity to xenobiotic induced morbidity/mortality in RBRC02414
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004417
increased circulating tumor necrosis factor level in RBRC00984
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001747
increased circulating alanine transaminase level in RBRC01236
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017923
hypoglycemia in RBRC02190
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003798
increased circulating interleukin-6 level in RBRC01236
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017947
abnormal physiological response to xenobiotic in RBRC00984
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010419
cachexia in RBRC02190
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003828
increased sensitivity to xenobiotic induced morbidity/mortality in RBRC01390
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002643
increased sensitivity to xenobiotic induced morbidity/mortality in RBRC02190
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003840
increased circulating tumor necrosis factor level in RBRC02414
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004414
liver inflammation in RBRC00984
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001714
cachexia in RBRC02414
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004405
cachexia in RBRC00984
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001738
abnormal physiological response to xenobiotic in RBRC01236
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017949
increased sensitivity to xenobiotic induced morbidity/mortality in RBRC00984
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001750
increased circulating interleukin-6 level in RBRC02190
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003838
increased hepatocyte apoptosis in RBRC02190
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003819
increased hepatocyte apoptosis in RBRC02414
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004396
increased hepatocyte apoptosis in RBRC00984
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001729
liver inflammation in RBRC01390
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002607
hypoglycemia in RBRC02414
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004375
hypoglycemia in RBRC01236
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017903
hepatic steatosis in RBRC01236
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017921
increased circulating interleukin-6 level in RBRC01390
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002641
abnormal physiological response to xenobiotic in RBRC02190
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010519
hepatic steatosis in RBRC02414
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004390
increased circulating interleukin-6 level in RBRC02414
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004415
hepatic steatosis in RBRC02190
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003813
abnormal physiological response to xenobiotic in RBRC01390
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010485
increased circulating alanine transaminase level in RBRC01390
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002618
increased hepatocyte apoptosis in RBRC01390
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002622
increased circulating tumor necrosis factor level in RBRC01390
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1002640
abnormal physiological response to xenobiotic in RBRC02414
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010537
increased circulating alanine transaminase level in RBRC02190
http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003815
お問い合わせ
システムのお問い合わせ
画像
足跡